Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 27 entries
View as:

A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03180710 Org: User:
Start: 06/06/17 End: 12/21/17 Due: 12/21/18

A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03916640 Org: User:
Start: 01/04/19 End: 03/01/19 Due: 03/01/20

A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

Phase: N/A Priority: Normal
NCT ID: NCT03179332 Org: User:
Start: 06/20/17 End: 09/27/17 Due: 09/27/18

A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02529293 Org: User:
Start: 08/31/15 End: 11/30/15 Due: 11/30/16

A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03981627 Org: User:
Start: 06/06/19 End: 06/27/20 Due: 06/27/21

A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02562326 Org: User:
Start: 09/30/15 End: 01/31/16 Due: 01/31/17

A Study of Insulin Lispro With BioChaperone Excipient in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01638325 Org: User:
Start: 07/31/12 End: 09/30/12 Due: 09/30/13

An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02660502 Org: User:
Start: 01/31/16 End: 05/31/16 Due: 05/31/17

A Trial Investigating the Dose Linearity and Safety of BC Combo THDB0207 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05373212 Org: User:
Start: 05/12/22 End: 01/02/23 Due: 01/02/24

A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03512236 Org: User:
Start: 04/25/18 End: 02/14/19 Due: 02/14/20

A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®

Phase: N/A Priority: Normal
NCT ID: NCT02562313 Org: User:
Start: 09/30/15 End: 11/30/16 Due: 11/30/17

A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02029924 Org: User:
Start: 12/31/13 End: 08/31/14 Due: 08/31/15

A Trial Investigating the Pharmacodynamics of BC Combo THDB0207 Compared With Humalog® Mix25 and Simultaneous Injections of Humalog® and Lantus® in Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05373186 Org: User:
Start: 05/12/22 End: 12/04/22 Due: 12/04/23

A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT02236793 Org: User:
Start: 12/31/14 End: 08/31/16 Due: 08/31/17

A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM

Phase: N/A Priority: Normal
NCT ID: NCT03176524 Org: User:
Start: 06/06/17 End: 09/04/17 Due: 09/04/18

A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02915250 Org: User:
Start: 10/31/16 End: 06/30/17 Due: 06/30/18

A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01981031 Org: User:
Start: 11/30/13 End: 08/31/14 Due: 08/31/15

A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02146651 Org: User:
Start: 05/31/14 End: 12/31/14 Due: 12/31/15

A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM

Phase: N/A Priority: Normal
NCT ID: NCT02739906 Org: User:
Start: 04/30/16 End: 08/31/16 Due: 08/31/17

A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)

Phase: N/A Priority: Normal
NCT ID: NCT04816890 Org: User:
Start: 03/23/21 End: 02/24/22 Due: 02/24/23

Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal

Phase: N/A Priority: Normal
NCT ID: NCT02344992 Org: User:
Start: 01/31/15 End: 06/30/15 Due: 06/30/16

A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05373199 Org: User:
Start: 05/12/22 End: 10/28/22 Due: 10/28/23

Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02514954 Org: User:
Start: 07/31/15 End: 11/30/15 Due: 11/30/16

A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02514850 Org: User:
Start: 07/31/15 End: 11/30/15 Due: 11/30/16

A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02213146 Org: User:
Start: 08/31/14 End: 06/30/15 Due: 06/30/16